First bioinformatics solution integrating new AMP/ASCO/CAP standards for NGS cancer testing to confidently and quickly report clinical relevance of somatic mutations Hilden, Germany, and Germantown, Maryland – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today launched enhancements in its QIAGEN Clinical Insight (QCI) bioinformatics software automating the AMP/ASCO/CAP Standards and Guidelines for the Interpretation and […]

Solution enables clinical labs that perform cancer NGS testing to quickly convert genomic insights to targeted therapies SALT LAKE CITY—-This week, at the Association for Molecular Pathology (AMP) Annual Meeting, Fabric Genomicswill announce its expanded somatic cancer solution which provides seamless genomic analysis and clinical reporting to clinical labs. The offering enables therapy matching for cancer […]

CAMBRIDGE, England Global Gene Corp today announced a collaboration with The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James), Department of Radiation Oncology, to develop a better understanding of rare cancers in South Asian and Indian populations. The collaboration with the OSUCCC – James […]

Increased Use of Physiologically-based Pharmacokinetic (PBPK) Modeling and Simulation (M&S)  is a Priority in Both the Prescription Drug User Fee Act and Generic Drug User Fee Amendments PRINCETON, NJ – Certara®, the global leader in model-informed drug development and regulatory science, today announced that the US Food and Drug Administration (FDA) has greatly expanded its use of […]

PORTLAND, OR and CAMBRIDGE, MA— MolecularMD announces that it has now become a Preferred Provider of Promega’s Microsatellite Instability (MSI) v1.2 Analysis System.  MolecularMD has completed validation of the MSI Analysis System for the analysis of multiple tumor types and is now offering the technology as part of a broader portfolio of diagnostic and clinical […]

HOUSTON — Genialis, Inc., a leading provider of cloud software for the visual exploration of next generation sequencing data, recently closed a $2.3M Seed round. The financing will accelerate the team’s expansion in the U.S. and commercialization of Genialis Platform. Redalpine Venture Capital in Zurich and First Star Venture Capital in Boston co-led the round, joined by Slovenian firm Pikas d.o.o. Several expert […]

Munich, Germany arivis AG will introduce its latest version of InViewR software at the 2017 Society for Neuroscience Meeting (SfN) November 11th – 15th in Washington, DC.  InViewR displays real image data in VR by utilizing patent pending direct volume rendering techniques with no need to convert data or make surface models. The latest InViewR sets […]

The Florida Department of Law Enforcement, Kansas City Police Crime Laboratory, Las Vegas Metropolitan Police Department, and Union County (NJ) Prosecutor’s Office Forensic Laboratory have joined 29 other U.S. labs in using STRmix,™ a sophisticated forensic software capable of resolving mixed DNA profiles previously thought to be too complex to interpret. STRmix™, the sophisticated forensic […]

NxClinical 4.0 is a revolutionary system that brings together cytogenetics and molecular genetics to increase diagnostic yield while decreasing costs for clinical labs performing variant interpretation. NxClinical 4.0 derives copy number and AOH changes directly from the same NGS assay used for sequence variant analysis, allowing integration of all genomic variations into a single database […]

Collaboration to Focus on Computational Chemistry and Molecular Recognition in the Human Body NEW YORK, NY and SHANGHAI, CHINA (November 7, 2017) – Schrödinger, Inc., a world-leading provider of advanced molecular simulations and drug discovery software solutions, and ShanghaiTech University in China have reached an agreement to develop a strategic partnership and establish the Shanghai […]